Findings showed a 13.6% reduction in body weight in the semaglutide 25 mg group compared with a 2.2% reduction in the placebo group.

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...

FYI, semaglutide belongs to a class of medications called glucagon-like peptide-1 receptor agonists (or, less of a mouthful, GLP-1s). There are a few different semaglutide drugs. Here’s a quick ...

With pharmaceutical GLP-1 drugs like semaglutide in high demand, Metamorphx offers a plant-based alternative designed to ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...

Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase 3, multicenter ...

Semaglutide improved maximum walking distance in patients with type 2 diabetes and symptomatic peripheral artery disease.

Safety and tolerability of semaglutide 25mg were consistent with the known profile for glucagon-like peptide-1 receptor agonists. Gastrointestinal side effects were the most commonly reported ...